Mechanistic pathways of malignancy in breast cancer stem cells
S Yousefnia, F Seyed Forootan… - Frontiers in …, 2020 - frontiersin.org
Breast cancer stem cells (BCSCs) are the minor population of breast cancer (BC) cells that
exhibit several phenotypes such as migration, invasion, self-renewal, and chemotherapy as …
exhibit several phenotypes such as migration, invasion, self-renewal, and chemotherapy as …
[HTML][HTML] Role, molecular mechanism and the potential target of breast cancer stem cells in breast cancer development
T Zhang, H Zhou, K Wang, X Wang, M Wang… - Biomedicine & …, 2022 - Elsevier
Breast cancer (BC) is one of the most common malignant tumors in women globally, and its
occurrence has surpassed lung cancer and become the biggest threat for women. At …
occurrence has surpassed lung cancer and become the biggest threat for women. At …
Signaling pathways governing breast cancer stem cells behavior
K Song, M Farzaneh - Stem Cell Research & Therapy, 2021 - Springer
Breast cancer is the second common cancer and the leading cause of malignancy among
females overall. Breast cancer stem cells (BCSCs) are a small population of breast cancer …
females overall. Breast cancer stem cells (BCSCs) are a small population of breast cancer …
Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications
A Ordaz-Ramos, O Tellez-Jimenez… - Frontiers in cell and …, 2023 - frontiersin.org
Breast cancer stem cells (BCSCs) represent a distinct subpopulation of cells with the ability
to self-renewal and differentiate into phenotypically diverse tumor cells. The involvement of …
to self-renewal and differentiate into phenotypically diverse tumor cells. The involvement of …
Targeting cellular signaling pathways in breast cancer stem cells and its implication for cancer treatment
BRB Pires, ÍSS DE AMORIM, LDE Souza… - Anticancer …, 2016 - ar.iiarjournals.org
Breast cancer is a public health problem both in developing and developed countries. The
breast cancer stem cell (BCSC) hypothesis has grown in the cancer research community …
breast cancer stem cell (BCSC) hypothesis has grown in the cancer research community …
Breast cancer stem cells
JS Crabtree, L Miele - Biomedicines, 2018 - mdpi.com
Breast cancer stem cells (BCSC) have been implicated in tumor initiation, progression,
metastasis, recurrence, and resistance to therapy. The origins of BCSCs remain …
metastasis, recurrence, and resistance to therapy. The origins of BCSCs remain …
MicroRNAs, a promising target for breast cancer stem cells
PK Das, MA Siddika, SY Asha, S Aktar… - Molecular Diagnosis & …, 2020 - Springer
Reactivation of the stem cell programme in breast cancer is significantly associated with
persistent cancer progression and therapeutic failure. Breast cancer stem cells (BCSCs) are …
persistent cancer progression and therapeutic failure. Breast cancer stem cells (BCSCs) are …
Breast cancer stem cells: Signaling pathways, cellular interactions, and therapeutic implications
Simple Summary Cancer stem cells (CSCs) in breast cancer have been identified for almost
two decades. Many outstanding discoveries have established the important functions of …
two decades. Many outstanding discoveries have established the important functions of …
MicroRNA regulation of human breast cancer stem cells
Y Shimono, J Mukohyama, S Nakamura… - Journal of clinical …, 2015 - mdpi.com
MicroRNAs (miRNAs) are involved in virtually all biological processes, including stem cell
maintenance, differentiation, and development. The dysregulation of miRNAs is associated …
maintenance, differentiation, and development. The dysregulation of miRNAs is associated …
Heterogeneity of tumors in breast cancer: implications and prospects for prognosis and therapeutics
N Tuasha, B Petros - Scientifica, 2020 - Wiley Online Library
Breast cancer is the most commonly diagnosed form of cancer in women comprising 16% of
all female cancers. The disease shows high intertumoral and intratumoral heterogeneity …
all female cancers. The disease shows high intertumoral and intratumoral heterogeneity …